newsfilter
← Latest News
Business Wire·

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

Genomic test using whole-transcriptome next-generation sequencing technology will be available to order on June 8 The Prosigna test predicts chemotherapy benefit and quantifies 10-year risk of recurrence to help